BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) completed its acquisition of Astria Therapeutics Inc. on January 23, following the initial announcement on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE